Literature DB >> 23188853

A unique presentation of four thrombotic events at a time.

Ali Raza Rajani1, Kosar Hussain, Fahad Omar Baslaib, Ghazi Ahmad Radaideh.   

Abstract

A 72-year-old man was referred to our hospital as a case of postcardiac arrest following a long distance air flight. Work-up in the emergency department revealed the presence of deep vein thrombosis (DVT), bilateral pulmonary embolism, inferior STEMI (ST elevation myocardial infarction) and ischaemic stroke. He received thrombolysis by recombinant tissue plasminogen activator (tPA) following which his haemodynamic status improved, but he developed haemorrhagic transformation of the stroke as a complication. The haemorrhagic lesion gradually resolved with conservative management, leaving behind a residual neurological deficit. His haemodynamic status was stable after the management. Although a diagnosis of right-to-left shunt lesion was highly suggestive in this condition, it could not be confirmed on the transthoracic echocardiogram. Our patient had a unique presentation of multiple thrombi in different organs that caused significant morbidity and haemodynamic instability. There are no well-established guidelines that discuss the acute management of such cases. This situation requires a careful assessment and management of the patient by a multidisciplinary team.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23188853      PMCID: PMC4543850          DOI: 10.1136/bcr-2012-007221

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  24 in total

1.  Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association.

Authors:  Michael R Jaff; M Sean McMurtry; Stephen L Archer; Mary Cushman; Neil Goldenberg; Samuel Z Goldhaber; J Stephen Jenkins; Jeffrey A Kline; Andrew D Michaels; Patricia Thistlethwaite; Suresh Vedantham; R James White; Brenda K Zierler
Journal:  Circulation       Date:  2011-03-21       Impact factor: 29.690

2.  PFO and paradoxical embolism producing events other than stroke.

Authors:  Catherine N Dao; Jonathan M Tobis
Journal:  Catheter Cardiovasc Interv       Date:  2011-03-16       Impact factor: 2.692

3.  Prevalence of myocardial scar in patients with cryptogenic cerebral ischemic events and patent foramen ovale.

Authors:  Jochen Wöhrle; Matthias Kochs; Vinzenz Hombach; Nico Merkle
Journal:  JACC Cardiovasc Imaging       Date:  2010-08

4.  Closure or medical therapy for cryptogenic stroke with patent foramen ovale.

Authors:  Anthony J Furlan; Mark Reisman; Joseph Massaro; Laura Mauri; Harold Adams; Gregory W Albers; Robert Felberg; Howard Herrmann; Saibal Kar; Michael Landzberg; Albert Raizner; Lawrence Wechsler
Journal:  N Engl J Med       Date:  2012-03-15       Impact factor: 91.245

5.  Association of a patent foramen ovale with myocardial infarction and pulmonary emboli in a peripartum woman.

Authors:  Rajesh Ramineni; George K Daniel
Journal:  Am J Med Sci       Date:  2010-10       Impact factor: 2.378

6.  [Paradoxical embolism and ischemia of the digestive tract].

Authors:  A Kaladji; F Gérard; C Audinet; A Cardon
Journal:  J Mal Vasc       Date:  2008-09-25

7.  Paradoxical embolism: a rare complication of thrombolysis.

Authors:  Y-F Liu; M Bayliss
Journal:  Emerg Med J       Date:  2008-03       Impact factor: 2.740

Review 8.  Common risk factors for both arterial and venous thrombosis.

Authors:  Gordon D O Lowe
Journal:  Br J Haematol       Date:  2008-03       Impact factor: 6.998

9.  [A case of renal paradoxical embolism].

Authors:  Pascal Cluzel; Ioana Enache; Jacques Ballout; Hubert Montoille; Jean-Christophe Eicher
Journal:  Nephrol Ther       Date:  2007-03-29       Impact factor: 0.722

10.  Cardiovascular risk factors and venous thromboembolism: a meta-analysis.

Authors:  Walter Ageno; Cecilia Becattini; Timothy Brighton; Rita Selby; Pieter W Kamphuisen
Journal:  Circulation       Date:  2007-12-17       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.